Related Experiment Video
Updated: May 4, 2026
08:16
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
2.1K
Adult tissue sources for new β cells
Robert J Nichols1, Connie New2, Justin P Annes2
1Department of Genetics, Stanford University, Stanford, Calif.
Translational Research : the Journal of Laboratory and Clinical Medicine
|December 19, 2013
Summary
Diabetes therapies are a priority due to rising costs. Research shows potential for regenerating insulin-producing beta cells from existing cells and other cell types in adults, offering new hope for diabetes treatment.
Area of Science:
- Endocrinology
- Regenerative Medicine
- Diabetes Research
Background:
- Diabetes poses significant public health and financial burdens.
- Current therapies aim to replace lost insulin-producing capacity.
- Beta-cell regeneration is a promising but unproven therapeutic strategy.
Purpose of the Study:
- To review recent advancements in endogenous beta-cell production.
- To explore the potential of beta-cell regeneration for diabetes therapy.
Main Methods:
- Review of experimental work on beta-cell regeneration.
- Elucidation of endogenous sources for new beta cells.
Main Results:
- Beta cells possess regenerative capacity, contrary to previous beliefs.
- Pancreatic facultative endocrine progenitor cells have been identified.
- Cellular identity malleability allows generation of beta cells from other cell types.
Conclusions:
- Emerging research highlights multiple endogenous sources for beta-cell regeneration.
- Regenerative therapies for diabetes using adult tissues show significant potential.
